Evidence map›Paper›PMID 39720559›Full record

ArticleToxicology reports2024

Occurrence of total aflatoxins (B1, B2, G1, G2) in commercial peanut and peanut butter from the Saudi market in the period from 2015 to 2020.

Abdullah Al Tamim, Rawan Alharbi, Zeyad Aldosari, Yaser Almasoud, Abdullah A Al Sayari, Mohammed A Almutairi, Abdullah M Alowaifeer, Hibah Alharbi

Abstract read
In one paragraph

Article in Toxicology reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Abdullah Al TamimSaudi Food & Drug Authority (SFDA), Riyadh 11561, Saudi Arabia.
Rawan AlharbiSaudi Food & Drug Authority (SFDA), Riyadh 11561, Saudi Arabia.
Zeyad AldosariSaudi Food & Drug Authority (SFDA), Riyadh 11561, Saudi Arabia.
Yaser AlmasoudSaudi Food & Drug Authority (SFDA), Riyadh 11561, Saudi Arabia.
Abdullah A Al SayariSaudi Food & Drug Authority (SFDA), Riyadh 11561, Saudi Arabia.
Mohammed A AlmutairiSaudi Food & Drug Authority (SFDA), Riyadh 11561, Saudi Arabia.
Abdullah M AlowaifeerSaudi Food & Drug Authority (SFDA), Riyadh 11561, Saudi Arabia.
Hibah AlharbiSaudi Food & Drug Authority (SFDA), Riyadh 11561, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nut products are susceptible to contamination with mycotoxin, especially aflatoxins, which results of mold growth during harvest or storage. This study aimed to evaluate the occurrence of aflatoxins in peanut products from the Saudi market. A total of 472 samples of peanut and peanut butter imported from various countries were collected in the period from 2015 to 2020. All samples were analyzed by High-Performance Liquid Chromatography (HPLC). Total aflatoxins (B1, B2, G1, G2) were found to exceed the maximum level (ML) in 38 samples (8.1 %) with a concentration range of 15.56-973.21 µg/kg, while 434 samples were below ML (91.9 %). Specifically, in Peanut butter samples, 27 out of 333 were contaminated with Aflatoxins (8.8 %), and 11 out of 139 peanut samples were contaminated with aflatoxins (8.6 %). The results show that the percentage of Aflatoxins contamination was reduced in the period (2019 - 2020) compared to (2015 - 2018), due to the control of mycotoxins in Saudi Arabia which played an important role in reducing the contamination of AFs in peanut products.

Indexed as

Aflatoxins B1 B2 G1 G2MycotoxinPeanutPeanut butter

Identifiers

PMID39720559
PMCPMC11667187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.